4//SEC Filing
Eichenfield Lawrence 4
Accession 0001209191-23-036149
CIK 0001660334other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 9:03 AM ET
Size
5.6 KB
Accession
0001209191-23-036149
Insider Transaction Report
Form 4
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-08+10,384→ 10,384 totalExercise: $5.70Exp: 2033-06-07→ Common Stock (10,384 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001814892
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 9:03 AM ET
- Size
- 5.6 KB